Literature DB >> 130239

Furosemide, mithramycin, and salmon calcitonin in hypercalcemia.

J P Filastre, G Humbert, J Leroy, J Maitrot, P Deshayes, M A Canonne.   

Abstract

Twenty-nine patients with acute hypercalcemia secondary to carcinoma, myeloma and parathyroid adenoma have been treated with large doses of furosemide, mithramycin, or salmon calcitonin perfusion. With furosemide administration the treatment was successful in 6 of 10 patients. Furosemide was injected intravenously at the rate of 125 mg every 3 hours. With mithramycin perfusion only 2 of 8 patients have a return of the serum calcium levels to normal. With salmon thyrocalcitonin 3 of 10 patients obtained a good result. It can be interesting to suggest the association of furosemide and salmon calcitonin infusion to treat hypercalcemia of myeloma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 130239     DOI: 10.1007/bf00624436

Source DB:  PubMed          Journal:  Eur J Intensive Care Med        ISSN: 0340-0964


  4 in total

1.  Renal function and alterations in plasma electrolyte levels in normocalcaemic and hypercalaemic patients with malignant diseases, given an intravenous infusion of mithramycin.

Authors:  J P Fillastre; J Maitrot; M A Canonne; H Gray; C Jeanne; P Bastit; T Bourgeois
Journal:  Chemotherapy       Date:  1974       Impact factor: 2.544

2.  Effect of diuretics on urinary excretion of phosphate, calcium, and magnesium in thyroparathyroidectomized dogs.

Authors:  G Eknoyan; W N Suki; M Martinez-Maldonado
Journal:  J Lab Clin Med       Date:  1970-08

3.  Acute treatment of hypercalcemia with furosemide.

Authors:  W N Suki; J J Yium; M Von Minden; C Saller-Hebert; G Eknoyan; M Martinez-Maldonado
Journal:  N Engl J Med       Date:  1970-10-15       Impact factor: 91.245

4.  Treatment of acute hypercalcemia with furosemide.

Authors:  J P Fillastre; G Humbert; J Leroy
Journal:  Curr Ther Res Clin Exp       Date:  1973-09
  4 in total
  4 in total

1.  Management of severe hypercalcaemia.

Authors: 
Journal:  Br Med J       Date:  1980-01-26

Review 2.  Salmon calcitonin in the acute management of hypercalcemia.

Authors:  L A Wisneski
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

Review 3.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Relative importance of renal failure and increased bone resorption in the hypercalcaemia of myelomatosis.

Authors:  P J Heyburn; J A Child; M Peacock
Journal:  J Clin Pathol       Date:  1981-01       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.